Ferring SAS, founded in St-Prex, Canton of Vaud, Switzerland, is a global pharmaceutical company committed to developing and marketing innovative treatments. The company's core mission is to help people live better lives by addressing unmet medical needs in the fields of gynecology, obstetrics, infertility, gastroenterology, urology, pediatrics, endocrinology, and orthopedics. Ferring's vision is to be a leader in reproductive medicine and maternal health while expanding its expertise in specialty areas. Their market focus spans across the globe, serving patients with a diverse range of health conditions.

Notable figures associated with Ferring include its leadership team and key investors who have driven the company's growth and innovation. Ferring has achieved significant milestones, including the development of pioneering treatments that have improved patient outcomes worldwide. The company's impact is evident in its contributions to advancing medical science and enhancing the quality of life for countless individuals. Through continuous research and development, Ferring remains at the forefront of addressing critical health challenges and fostering global health improvements.